Director / Portfolio Project Lead
Pfizer
Christina Van Geen Hoven is a Director at Pfizer in Andover, MA, currently serving as the mRNA Drug Product Portfolio Lead in the Pharmaceutical Research and Development Group. She brings over 25 years of experience in drug product development and manufacturing, with deep expertise in complex formulation technologies. Christina earned her B.A. in Biology from Boston University and began her career at Alkermes, where she worked on process development and manufacturing of long-acting injectable formulations utilizing polymeric microsphere technology. She then joined BIND Therapeutics, working on various oncology indications, as a process engineer and eventually became Head of Manufacturing leading the transfer of complex nanoparticle processes to multiple contract manufacturing organizations. Following BIND’s acquisition by Pfizer, Christina continued to lead drug product programs using the BIND technology and has also served as a group lead. During the COVID-19 pandemic, she played a key role in developing Pfizer’s vaccine, focusing on tech transfer to manufacturing sites. Christina now supports all current mRNA drug product programs in research and development as the Portfolio Project Lead.
Disclosure information not submitted.
Manufacturing Considerations for mRNA LNP-Based Drug Products
Monday, November 10, 2025
3:45 PM - 4:00 PM CT